Buying vs. Building Healthcare Data: What the Spreadsheet Doesn't Tell You | NPLUS Global

We had a client last year — mid-size medical device company, decent SDR team, reasonable budget — who decided to build their own list of hospital procurement contacts instead of buying one. Not because anyone ran a formal cost analysis. It just felt more responsible. "We'll own the data," someone said in a planning meeting. Six months later they had a spreadsheet of 4,200 names, about 30% of which were already stale by the time outreach started, and two analysts who'd spent a quarter doing something that wasn't really their job. That's the story we want to talk about, because the build-vs-buy math in healthcare is almost never about the spreadsheet. It's about what else your team stops doing while they build it.

The Labor Cost Nobody Puts in the Budget Line

When companies model "building in-house," they usually cost out the tool subscriptions — a LinkedIn Sales Navigator seat, maybe a scraping tool, maybe an NPI database license — and call it done. What they don't cost out is the time. Healthcare org charts are not LinkedIn-friendly. A hospital's actual decision-making structure for, say, capital equipment purchases, often has almost nothing to do with the titles people list publicly. You'll find a "Director of Perioperative Services" who has zero budget authority and a "Clinical Systems Analyst" who quietly runs the vendor evaluation process. Figuring that out takes someone who understands hospital operations, not just someone who's good at Boolean search strings.

We've watched internal teams burn weeks just untangling health system parent-subsidiary relationships — is this clinic billing under the regional health system or still independent, did that acquisition close, does the facility NPI match the org NPI. None of that shows up in a "cost of building a list" estimate, but it's most of the actual work. The people doing that work are usually your better marketing ops or sales enablement staff, which means the real cost isn't the hours — it's the opportunity cost of pulling your most capable people off of campaign execution, lead scoring, whatever they were supposed to be doing, and putting them on data janitorial work instead.

Turnover Is the Silent Budget Killer

Healthcare has genuinely brutal contact churn compared to most other B2B verticals — physicians switch practice groups, hospital administrators get reorganized every time there's a merger, procurement roles get renamed and reshuffled after every EHR transition. A list that's accurate in January can be meaningfully degraded by June. That's true whether you bought it or built it, but it hits differently depending on which one you did.

If you bought the list, degradation is priced in — a reasonable vendor accounts for refresh cycles, and you can push back on them contractually if the data goes stale faster than promised. If you built it yourself, degradation is just... your problem, quietly. Nobody budgets for the ongoing maintenance of an in-house list because nobody wants to admit that "building the list" was never a one-time project. It's a standing commitment. We've seen teams build something solid, feel good about it for two quarters, and then watch reply rates and match rates slide because nobody owned the upkeep once the original project wrapped and everyone moved on to the next initiative. The list doesn't announce that it's decaying. Your pipeline numbers just get quietly worse and everyone blames messaging.

Buying Isn't Automatically Cheaper — It's Differently Risky

We don't want to overcorrect into "just buy data, it's obviously better," because that's its own kind of naive. Purchased healthcare data carries its own failure modes, and they're worth naming honestly. Compliance risk is real — healthcare has enough regulatory texture around how contact and provider information can be sourced and used that a cheap list from an unclear provenance can create actual legal exposure, not just bad conversion rates. Coverage gaps are real too — a vendor might be excellent on hospital-based specialists and thin on ambulatory surgery centers or behavioral health, and you won't necessarily know that until your campaign underperforms in exactly those segments.

There's also a trust problem that's specific to this industry: healthcare buyers are more skeptical of unsolicited outreach than almost any other vertical we work in, partly because they get so much of it, and partly because a lot of it is clearly built on bad data — wrong titles, wrong facilities, people who left two years ago. A purchased list that's poorly matched to your actual ICP does more reputational damage in healthcare than a mediocre list would in, say, retail or SaaS, because clinical and administrative audiences remember who wasted their time. So "buying" only pays off if the data is actually validated against something real — NPI records, current facility affiliations, licensure status — not just scraped and repackaged. This is the part of our own work at NPLUS Global that we think about constantly: the value isn't the list itself, it's whether someone did the unglamorous verification work behind it recently enough for it to matter.

Where This Actually Nets Out

The honest answer, based on what we've watched across a fair number of accounts, is that build-vs-buy isn't really a cost question — it's a question about what your team is structurally good at. If you have people who genuinely understand healthcare organizational structures, who enjoy the detective work of untangling facility hierarchies, and who have the bandwidth to treat list maintenance as ongoing infrastructure rather than a one-off project, building can work, and it can produce something more precisely tuned to your specific use case than anything you'd buy. That's a real team, doing real specialized work, and it's rarer than people think.

For most teams — including plenty who are convinced they're the exception — the more honest framing is that building in-house isn't "free," it's just a cost that shows up as slower time-to-pipeline, distracted senior staff, and a maintenance obligation that outlives the original project owner. Buying isn't automatically cheaper, but it converts an open-ended internal labor cost into a fixed, comparable line item, which at least lets you evaluate it honestly against what your team's time is actually worth. That comparison — not the sticker price of a data subscription — is the one worth running before anyone commits a quarter of analyst time to a spreadsheet.